Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$10.28 USD
+0.11 (1.08%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Earnings News For FOLD
-
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
-
Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates
-
Amicus Therapeutics (FOLD) Reports Q4 Loss, Lags Revenue Estimates
-
Why Is Amicus Therapeutics (FOLD) Up 15% Since Last Earnings Report?
-
Amicus' (FOLD) Q3 Loss Narrows, Galafold Sales View Updated
-
Amicus Therapeutics: Q3 Earnings Snapshot
-
Amicus Therapeutics (FOLD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Why Is Amicus Therapeutics (FOLD) Down 6.8% Since Last Earnings Report?
-
Amicus (FOLD) Misses on Q2 Earnings, Raises Revenue Guidance
-
Amicus Therapeutics (FOLD) Reports Q2 Loss, Tops Revenue Estimates
-
Amicus Therapeutics: Q2 Earnings Snapshot
-
Why Is Amicus Therapeutics (FOLD) Up 8.1% Since Last Earnings Report?
-
Amicus (FOLD) Q1 Earnings Miss, Galafold Sales Grow
-
Amicus Therapeutics (FOLD) Reports Q1 Loss, Tops Revenue Estimates
-
Amicus Therapeutics: Q1 Earnings Snapshot
-
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
-
Amicus Therapeutics (FOLD) Down 14% Since Last Earnings Report: Can It Rebound?
-
Amicus (FOLD) Q4 Earnings Miss, Galafold Sales Beat Estimates
-
Amicus Therapeutics (FOLD) Reports Q4 Loss, Tops Revenue Estimates
-
Why Is Amicus Therapeutics (FOLD) Up 13.7% Since Last Earnings Report?
-
Amicus (FOLD) Q3 Earnings Beat, Galafold Sales Miss Estimates
-
Amicus Therapeutics (FOLD) Reports Q3 Loss, Misses Revenue Estimates
-
Amicus Therapeutics: Q3 Earnings Snapshot
-
Amicus (FOLD) Q2 Earnings Beat, Galafold Sales Miss Estimates
-
Amicus Therapeutics: Q2 Earnings Snapshot